000 | 01956ngm a2200433 a 4500 | ||
---|---|---|---|
001 | HST3290_1_2 | ||
003 | UkLoHST | ||
006 | m c | ||
007 | cr|cna|||a|||| | ||
007 | vz|czazum | ||
008 | 121016s2012 enk|||||||||||s|||v|eng d | ||
028 | 5 | 0 |
_a3290 _bHenry Stewart Talks |
035 | _a(UkLoHST)2399 | ||
040 |
_aUkLoHST _beng _cUkLoHST |
||
100 | 1 |
_aHarris, Tim, _u(Biogen Idec., USA) _4spk |
|
245 | 1 | 0 |
_aPatient stratification for drug treatment in oncology and other diseases _h[electronic resource] / _cTim Harris. |
260 |
_aLondon : _bHenry Stewart Talks, _c2012. |
||
300 |
_a1 online resource (1 streaming video file (41 min.) : _bcolor, sound). |
||
490 | 1 |
_aBiomarkers : the path forward to highly sensitive and specific molecular diagnostics, _x2056-452X |
|
500 | _aAnimated audio-visual presentation with synchronized narration. | ||
500 | _aTitle from title frames. | ||
505 | 0 | _aContents: Personalised medicine in Oncology -- Patient stratification using molecular markers -- Next generation genome sequencing and data handling -- Drivers of patient stratification including payors -- Molecular profiling in lung and breast cancer -- Relevance of these approaches for ALS, MS and other neurological diseases. | |
506 | _aAccess restricted to subscribers. | ||
538 | _aMode of access: World Wide Web. | ||
650 | 0 | _aAntineoplastic agents. | |
650 | 0 |
_aBiochemical markers _xDiagnostic use. |
|
650 | 0 |
_aCancer _xChemotherapy. |
|
650 | 0 |
_aDrugs _xDesign. |
|
650 | 0 | _aMolecular diagnosis. | |
650 | 2 | _aAntineoplastic Agents. | |
650 | 2 | _aBiomarkers, Pharmacological. | |
650 | 2 | _aDrug Design. | |
650 | 2 |
_aNeoplasms _xdrug therapy. |
|
650 | 2 |
_aNeoplasms _xgenetics. |
|
650 | 2 | _aPrecision Medicine. | |
830 | 0 |
_aHenry Stewart talks. _pBiomedical & life sciences collection. _pBiomarkers. |
|
856 | 4 | 0 | _uhttps://hstalks.com/bs/2399/ |
856 | 4 | 2 |
_uhttps://hstalks.com/bs/p/666/ _3Series |
999 |
_c77334 _d77334 |